Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best debt-free penny stocks to buy right now. On December 17, ...

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by Antique-Reference585. In this article, we ...

Hi, everyone. Let's get started. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Priyanka Grover, and I'm part of the JPMorgan Biotech team. Today, our next presenting company is ...

Poetiq was launched last year by former Google DeepMind researchers Shumeet Baluja and Ian Fischer. Baluja established the ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Investing.com - Recursion Pharmaceuticals (NASDAQ: RXRX) reported fourth quarter EPS of $-0.31, $0.02 worse than the analyst ...

According to TipRanks.com, Blum is a 4-star analyst with an average return of 7.7% and a 39.5% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., ...

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...

The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...

The raise comes less than two months after Ricursive was launched by former Google LLC researchers Anna Goldie and Azalia ...